anti-HER2 CAR macrophage therapy (The Affiliated Hospital of Xuzhou Medical University)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameanti-HER2 CAR macrophage therapy (The Affiliated Hospital of Xuzhou Medical University)

Drug Alias NameCAR-M cells

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Macrophages therapy

Mechanisms of ActionImmunostimulantsReceptor protein-tyrosine kinase erbB-2 modulatorsMacrophages stimulants

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesThe Affiliated Hospital Of Xuzhou Medical University

China Registration ClassN/A

Develop Information

Active CompaniesThe Affiliated Hospital Of Xuzhou Medical University

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A